AEON Biopharma
AEON
AEON
71 hedge funds and large institutions have $202M invested in AEON Biopharma in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
Holders
71
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$9.78M | |
| 2 | +$4.69M | |
| 3 | +$4.23M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.48M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.35M |
Top Sellers
| 1 | -$4.99M | |
| 2 | -$4.5M | |
| 3 | -$2.76M | |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$2.06M |
| 5 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$1.84M |